Tobacco Products Scientific Advisory Committee

Last updated

The Tobacco Products Scientific Advisory Committee (TPSAC) is an advisory panel of the United States Food and Drug Administration organized to provide advice, information and recommendations to the FDA commissioner on matters related to the regulation of tobacco products. [1] It was created in accordance to the Family Smoking Prevention and Tobacco Control Act, signed into law by President Barack Obama on June 22, 2009. [2] The Committee was inaugurated during its March 30–31, 2010 meeting. [1]

Contents

Structure and mission

TPSAC consists of 12 members, including a chairperson, all of whom are selected by the FDA commissioner from among experts in medicine, medical ethics, science and technology related to the manufacture and use of tobacco products. Nine voting seats are held for academics and practitioners in the field of health care, while three non-voting seats are held for industry representatives. Members serve for overlapping terms of four years. [1] Meetings are held approximately four times per year, with all meetings publicly announced in the Federal Register at least 15 days before each meeting.

The Committee's purpose is to review and evaluate safety, dependence, and health issues relating to tobacco products and to provide appropriate advice, information and recommendations to the Commissioner of Food and Drugs on the following topics: [1]

Membership

Voting members

Non-voting members

Controversy

On March 1, 2010, the Wall Street Journal reported that proposed committee members Jack Henningfield and Neal L. Benowitz, had served as consultants to GlaxoSmithKline, and Benowitz to Pfizer as well, both pharmaceutical firms that market smoking cessation drugs. [4] Their selection by the FDA has drawn criticism as "lax on conflict of interest" by the Boston Globe . [5] Meanwhile, advocacy group Americans for Limited Government has raised concerns about funding received by TPSAC chair Jonathan Samet from GlaxoSmithKline and other pharmaceutical companies. [6] In January 2011, Gregory N. Connolly resigned from the committee following allegations of conflicts of interest citing payments to provide deposition or trial testimony in lawsuits against tobacco companies. [7]

In February 2011, Lorillard and R.J. Reynolds filed a federal lawsuit to try to block the advisory committee action or force the FDA to disregard its advice, stating three of the eight panel members had financial conflicts of interest from legal and consulting work against tobacco companies. [8] [9] On July 21, 2014, U.S. District Court Judge Richard Leon (Washington, DC) ruled that "FDA erred in determining that the members didn't have conflicts of interest" and that the appointments were arbitrary and capricious. [10] FDA was also ordered to reconstitute the TPSAC. [10]

TPSAC Decision on Menthol Cigarettes

On March 18, 2011 the panel concluded that removing menthol cigarettes from the market would benefit public health in the United States, but stopped short of recommending that the FDA take any specific actions like restricting or banning the additive. A progress report on panel findings is expected in July 2011. [9]

In March 2011, the tobacco industry released a report to the FDA in response to the TPSAC decision claiming menthol cigarettes are no riskier than regular cigarettes and should not be regulated differently. [11] The U.S. District Court decision from July 21, 2014 ruled that "Conflicts of interest — whether actual or perceived — undermine the public's confidence in the agency's decision-making process and render its final product suspect", [10] blocking the TPSAC report on menthol cigarettes from being used for regulatory purposes.

TPSAC Interactive Public Docket

An Interactive Public Docket on the TPSAC was established to allow interested members of the public to discuss the Committee's work. [12] The IPD includes discussion forums on TPSAC sub-topics including Studies and Concepts Under Review, Member Statements and Committee Governance.

Related Research Articles

<span class="mw-page-title-main">Cigarette</span> Small roll of tobacco made to be smoked

A cigarette is a narrow cylinder containing a combustible material, typically tobacco, that is rolled into thin paper for smoking. The cigarette is ignited at one end, causing it to smolder; the resulting smoke is orally inhaled via the opposite end. Cigarette smoking is the most common method of tobacco consumption. The term cigarette, as commonly used, refers to a tobacco cigarette, but the word is sometimes used to refer to other substances, such as a cannabis cigarette or a herbal cigarette. A cigarette is distinguished from a cigar by its usually smaller size, use of processed leaf, different smoking method, and paper wrapping, which is typically white.

<span class="mw-page-title-main">Kool (cigarette)</span> American brand of menthol cigarettes

Kool is an American brand of menthol cigarette, currently owned and manufactured by ITG Brands LLC, a subsidiary of Imperial Tobacco Company. Kool cigarettes sold outside of the United States are manufactured by British American Tobacco.

<span class="mw-page-title-main">Kretek</span> Type of Indonesian cigarette including cloves

Kretek are cigarettes of Indonesian origin, made with a blend of tobacco, cloves, and other flavors. They are available filtered or unfiltered. The word "kretek" itself is an onomatopoetic term for the crackling sound of burning cloves.

Newport is an American brand of menthol cigarettes, currently owned and manufactured by the R. J. Reynolds Tobacco Company. The brand was originally named for the seaport of Newport, Rhode Island.

<span class="mw-page-title-main">Philip Morris International</span> U.S.A. multinational tobacco company

Philip Morris International Inc. (PMI) is an American multinational tobacco company, with products sold in over 180 countries. The most recognized and best selling product of the company is Marlboro. Philip Morris International is often referred to as one of the companies comprising Big Tobacco.

<span class="mw-page-title-main">Lorillard Tobacco Company</span> Tobacco firm

Lorillard Tobacco Company was an American tobacco company that marketed cigarettes under the brand names Newport, Maverick, Old Gold, Kent, True, Satin, and Max. The company had two operating segments: cigarettes and electronic cigarettes.

An herbal cigarette is a cigarette that usually does not contain any tobacco or nicotine, instead being composed of a mixture of various herbs and/or other plant material. However, Chinese herbal cigarettes contain tobacco and nicotine with herbs added, unlike European and North American herbal cigarettes which have tobacco and nicotine omitted. Like herbal smokeless tobacco, they are often used as a substitute for standard tobacco products. Herbal cigarettes are often advertised as a smoking cessation aid. They are also used in acting scenes by performers who are non-smokers, or where anti-smoking legislation prohibits the use of tobacco in public spaces. Herbal cigarettes can carry carcinogens.

<span class="mw-page-title-main">Menthol cigarette</span> Cigarette flavored with the compound menthol

A menthol cigarette is a cigarette infused with the compound menthol which imparts a “minty” flavor to the smoke. Menthol also decreases irritant sensations from nicotine by desensitizing receptors, making smoking feel less harsh compared to regular cigarettes. Some studies have suggested that they are more addictive. Menthol cigarettes are just as hard to quit and are just as harmful as regular cigarettes.

<span class="mw-page-title-main">Flavored tobacco</span> Tobacco product with added flavorings

Flavored tobacco products — tobacco products with added flavorings — include types of cigarettes, cigarillos and cigars, hookahs and hookah tobacco, various types of smokeless tobacco, and more recently electronic cigarettes. Flavored tobacco products are especially popular with youth and have therefore become targets of regulation in several countries.

Ventilated cigarettes are considered to have a milder flavor than regular cigarettes. These cigarette brands may be listed as having lower levels of tar ("low-tar"), nicotine, or other chemicals as "inhaled" by a "smoking machine". However, the scientific evidence is that switching from regular to light or low-tar cigarettes does not reduce the health risks of smoking or lower the smoker's exposure to the nicotine, tar, and carcinogens present in cigarette smoke.

<span class="mw-page-title-main">Family Smoking Prevention and Tobacco Control Act</span>

The Family Smoking Prevention and Tobacco Control Act, is a federal statute in the United States that was signed into law by President Barack Obama on June 22, 2009. The Act gives the Food and Drug Administration the power to regulate the tobacco industry. A signature element of the law imposes new warnings and labels on tobacco packaging and their advertisements, with the goal of discouraging minors and young adults from smoking. The Act also bans flavored cigarettes, places limits on the advertising of tobacco products to minors and requires tobacco companies to seek FDA approval for new tobacco products.

Dissolvable tobacco is a smokeless tobacco product that dissolves in the mouth. Major tobacco manufacturers that sell dissolvable tobacco products include R. J. Reynolds Tobacco Company. Research into health effects of dissolvable and other new tobacco products was among the reasons of the establishment of the Tobacco Products Scientific Advisory Committee of the Food and Drug Administration in 2009.

Tobacco has a long cultural, economic, and social history in the United States. Tobacco cultivation near Jamestown, Virgina Colony, in 1610 was the beginning of the plant's development as a cash crop with a strong demand in England. By the beginning of the 18th century, tobacco became a significant economic force in the American colonies, especially in Virginia's tidewater region surrounding Chesapeake Bay. Vast plantations were built along rivers, and socioeconomic systems were developed to grow and distribute the crop. In 1713, the Virginia General Assembly passed a Tobacco Act requiring the inspection of all tobacco intended for export or for use as legal tender. American tobacco farmers sold their crops on consignment to merchants in London, which required them to take out loans for farm expenses from London guarantors in exchange for tobacco delivery and sale. As the demand for tobacco grew in continental Europe, further colonization and tobacco production in British America saw a parallel increase, and tobacco cultivation spread into Britain's other Southern Colonies and beyond. A brisk trade developed among wholesalers in Charleston and New Orleans to ship tobacco to London merchants. Tobacco use had also become common in early American society and was heavily consumed before and after the declaration of American independence in 1776.

<span class="mw-page-title-main">Regulation of tobacco by the U.S. Food and Drug Administration</span>

Regulation of tobacco by the U.S. Food and Drug Administration began in 2009 with the passage of the Family Smoking Prevention and Tobacco Control Act by the United States Congress. With this statute, the Food and Drug Administration (FDA) was given the ability to regulate tobacco products.

<span class="mw-page-title-main">True (cigarette)</span> American brand of cigarettes

True is an American brand of cigarettes, currently owned by Reynolds American and manufactured through its subsidiary R.J. Reynolds. The brand was created and formerly owned by the Lorillard Tobacco Company.

<span class="mw-page-title-main">Blu (electronic cigarette)</span> Electronic cigarette brand

Blu is an electronic cigarette brand, produced by Fontem Ventures and owned by Imperial Brands. The brand Blu sells various types of rechargeable and disposable e-cigarettes with a wide selection of flavored and unflavored liquids. Its products are available in many countries and each market offers different types of products suited to public demand and opportunities. The global headquarters of Blu is located in Amsterdam. Local offices are active around the world to service all markets which sell the brand.

<span class="mw-page-title-main">Modified risk tobacco product</span> United States legal designation

A modified risk tobacco product (MRTP) is a legal designation in the United States for a tobacco product that poses lower health risks to individual users and the population as a whole when compared to existing products on the market such as cigarettes. The Family Smoking Prevention and Tobacco Control Act of 2009 gives the US Food and Drug Administration (FDA) broad authority to regulate tobacco products; the FDA's power extends to approving or rejecting MRTP applications.

Neal L. Benowitz is an American academic physician and professor of medicine at the University of California, San Francisco (UCSF), with expertise on the pharmacology of nicotine and tobacco addiction.

<span class="mw-page-title-main">Scott Gottlieb</span> American physician and government administrator (born 1972)

Scott Gottlieb is an American physician, investor, and author who served as the 23rd commissioner of the Food and Drug Administration (FDA) from May 2017 until April 2019. He is presently a senior fellow at the conservative think tank the American Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), a member of the board of directors of drug maker Pfizer, Inc and gene sequencing company Illumina, Inc. and a contributor to cable financial news network CNBC and the CBS News program Face the Nation. An elected member of the National Academy of Medicine, Gottlieb is the author of The New York Times best selling book Uncontrolled Spread on the COVID-19 pandemic and the national security vulnerabilities that it revealed. His forthcoming book, The Miracle Century: Making Sense of the Cell Therapy Revolution, traces the scientific achievements that propelled progress in cell therapies.

<span class="mw-page-title-main">Brian King (epidemiologist)</span> American epidemiologist (born 1982)

Brian King is an American Epidemiologist who currently serves as the Director of the Food and Drug Administration's Center for Tobacco Products (CTP). He was appointed to his role in July 2022.

References

  1. 1 2 3 4 Tobacco Products Scientific Advisory Committee
  2. ↑ Occasional Smoker, 47, Signs Tobacco Bill, Jeff Zeleny, New York Times, June 22, 2009.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 Roster of the Tobacco Products Scientific Advisory Committee (retrieved April 1, 2010)
  4. ↑ FDA Tobacco Panel Includes Members With Quit-Smoking Ties, Wall Street Journal, David Kesmodel and Jared A. Favole, March 1, 2010.
  5. ↑ FDA lax on conflicts of interest, Boston Globe, March 8, 2010
  6. ↑ ALG Calls On Administration to Dismiss Science Panel Members With Conflicts Archived 2010-06-18 at the Wayback Machine , March 31, 2010.
  7. ↑ Kesmodel, David (5 January 2011). "FDA Tobacco Adviser Resigns". Wall Street Journal. Retrieved 27 July 2011.
  8. ↑ "Lorillard suit accuses FDA panel of bias". The Business Journal. 25 February 2011. Retrieved 27 July 2011.
  9. 1 2 Wilson, Duff (18 March 2011). "Advisory Panel Urges F.D.A. to Re-examine Menthol in Cigarettes". New York Times. Retrieved 27 July 2011.
  10. 1 2 3 "Lorillard Inc vs. Food and Drug Administration". ecf.dcd.uscourts.gov. United States District Court for the District of Columbia. July 21, 2014. Archived from the original on February 22, 2015. Retrieved 20 May 2023.
  11. ↑ "Tobacco makers fight menthol rules". Associated Press. 18 March 2011. Archived from the original on 27 April 2012. Retrieved 27 July 2011.
  12. ↑ TPSAC IPD
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.